What does CUSIP 036752103 represent in this 13F holders report?

CUSIP 036752103 is the security identifier for ELV - Elevance Health, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ELV - Elevance Health, Inc. - Common Stock in Q2 2019?

1017 institutional investors reported ELV - Elevance Health, Inc. - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 225,970,109
Total 13F shares: 227,616,918
Share change: +5,507,775
Total reported value: $64,170,095,418
Put/Call ratio: 82%
Price per share: $282.21
Number of holders: 1,017
Value change: +$1,536,564,497
Number of buys: 486
Number of sells: 497

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 036752103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.7%	22,017,312	$6,318,529,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	8.6%	19,324,131	$5,545,640,000	—	31 Mar 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	8.5%	19,284,651	$5,534,309,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	5%	11,334,274	$3,252,710,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	4.6%	10,439,398	$2,995,897,000	—	31 Mar 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.6%	8,170,351	$2,344,727,000	—	31 Mar 2019	13F
VIKING GLOBAL INVESTORS LP	13F	Company	2.7%	6,194,886	$1,777,808,000	—	31 Mar 2019	13F
BAILLIE GIFFORD & CO	13F	Company	2%	4,425,088	$1,269,912,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	3,628,374	$1,039,609,000	—	31 Mar 2019	13F
Invesco Ltd.	13F	Company	1.5%	3,463,533	$993,963,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	1.4%	3,122,110	$895,982,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	2,941,303	$844,030,000	—	31 Mar 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.2%	2,789,388	$800,499,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.2%	2,642,366	$758,306,000	—	31 Mar 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1.2%	2,613,087	$740,471,000	—	31 Mar 2019	13F
NORGES BANK	13F	Company	1.1%	2,539,789	$728,868,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	1.1%	2,517,677	$722,522,000	—	31 Mar 2019	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	1.1%	2,491,371	$714,978,000	—	31 Mar 2019	13F
OppenheimerFunds, Inc.	13F	Company	1.1%	2,464,719	$707,325,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	1%	2,363,637	$678,316,000	—	31 Mar 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.99%	2,245,114	$644,305,000	—	31 Mar 2019	13F
Sanders Capital, LLC	13F	Company	0.88%	1,995,147	$572,567,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.88%	1,991,802	$571,607,000	—	31 Mar 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.88%	1,988,636	$570,698,759	—	31 Mar 2019	13F
Orbis Allan Gray Ltd	13F	Company	0.87%	1,955,588	$561,215,000	—	31 Mar 2019	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	0.84%	1,899,858	$545,221,000	—	31 Mar 2019	13F
First Eagle Investment Management, LLC	13F	Company	0.81%	1,837,393	$527,295,000	—	31 Mar 2019	13F
Boston Partners	13F	Company	0.81%	1,819,947	$522,288,000	—	31 Mar 2019	13F
Legal & General Group Plc	13F	Company	0.76%	1,719,539	$493,442,000	—	31 Mar 2019	13F
Artisan Partners Limited Partnership	13F	Company	0.72%	1,627,676	$467,110,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.69%	1,564,454	$448,966,000	—	31 Mar 2019	13F
Capital International Investors	13F	Company	0.65%	1,476,836	$423,822,000	—	31 Mar 2019	13F
APG Asset Management N.V.	13F	Company	0.66%	1,493,612	$381,740,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.54%	1,209,917	$347,222,000	—	31 Mar 2019	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	0.53%	1,204,317	$345,615,000	—	31 Mar 2019	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.52%	1,184,357	$339,887,000	—	31 Mar 2019	13F
CI INVESTMENTS INC.	13F	Company	0.52%	1,177,177	$337,826,000	—	31 Mar 2019	13F
Gestion Carmignac	13F	Individual	0.52%	1,174,465	$337,048,000	—	31 Mar 2019	13F
ROYAL BANK OF CANADA	13F	Company	0.47%	1,065,804	$305,865,000	—	31 Mar 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.46%	1,042,553	$299,192,000	—	31 Mar 2019	13F
GLENVIEW CAPITAL MANAGEMENT, LLC	13F	Company	0.45%	1,018,237	$292,214,000	—	31 Mar 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.44%	998,574	$286,571,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.44%	996,755	$286,049,000	—	31 Mar 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.43%	975,678	$278,121,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.41%	934,341	$268,137,000	—	31 Mar 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.41%	930,483	$267,246,000	—	31 Mar 2019	13F
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	13F	Company	0.38%	865,846	$248,481,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.38%	856,995	$245,933,000	—	31 Mar 2019	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.37%	825,000	$236,759,000	—	31 Mar 2019	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	0.36%	811,004	$232,742,000	—	31 Mar 2019	13F

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2019

As of 30 Jun 2019, Elevance Health, Inc. - Common Stock (ELV) was held by 1,017 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 227,616,918 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., Viking Global Investors LP, BAILLIE GIFFORD & CO, and BARROW HANLEY MEWHINNEY & STRAUSS LLC. This page lists 1,018 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

1,060

Q2 2019 holders

1,017

Holder diff

-43

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.